DISCOUNT ZERTIFIKAT - ABBVIE Share Price

Certificat

DE000PN7J7Q0

Market Closed - Deutsche Boerse AG 01:10:12 08/06/2024 am IST
155.2 EUR +1.33% Intraday chart for DISCOUNT ZERTIFIKAT - ABBVIE
Current month+6.06%
1 month+3.47%
Date Price Change
07/24/07 155.2 +1.33%
06/24/06 153.2 +1.33%
05/24/05 151.2 +1.61%
04/24/04 148.8 +1.43%
03/24/03 146.7 +0.23%

Delayed Quote Deutsche Boerse AG

Last update June 08, 2024 at 01:10 am IST

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7J7Q
ISINDE000PN7J7Q0
Date issued 18/08/2023
Maturity 21/06/2024 (14 Days)
Parity 1 : 1
Emission price 130.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 155.2
Lowest since issue 122.3

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
169.4 USD
Average target price
183 USD
Spread / Average Target
+8.04%
Consensus